{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:13:55Z","timestamp":1788754435721,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00894-021-04816-y","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T23:04:30Z","timestamp":1624575870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2"],"prefix":"10.1007","volume":"27","author":[{"given":"Sajjad","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5789-4215","authenticated-orcid":false,"given":"Yasir","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Abro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumra Wajid","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"key":"4816_CR1","doi-asserted-by":"crossref","unstructured":"Li, H., Liu, S.-M., Yu, X.-H., Tang, S.L. and Tang, C.K.:\u00a0Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int. J. Antimicrob. Agents. 55(5), 105951 (2020)","DOI":"10.1016\/j.ijantimicag.2020.105951"},{"key":"4816_CR2","doi-asserted-by":"crossref","unstructured":"Hirano, T., Murakami, M.: COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity 52(2), 731-733 (2020)","DOI":"10.1016\/j.immuni.2020.04.003"},{"key":"4816_CR3","doi-asserted-by":"crossref","unstructured":"Chakraborty, I., Maity, P.: COVID-19 outbreak: Migration, effects on society, global environment and prevention. Sci. Total. Environ. 728, 138882 (2020)","DOI":"10.1016\/j.scitotenv.2020.138882"},{"key":"4816_CR4","doi-asserted-by":"crossref","unstructured":"Wang, L., Wang, Y., Ye D, Liu, Q.: Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int. J. Antimicrob. Agents. 55(6), 105948 (2020)","DOI":"10.1016\/j.ijantimicag.2020.105948"},{"key":"4816_CR5","unstructured":"Ghebreyesus TA (2020) WHODirector-General\u2019s opening remarks at the media briefing on COVID-19-11 March 2020. World Health Organization. Downloaded fromhttps:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.\u00a0Accessed 21 June, 2021"},{"key":"4816_CR6","doi-asserted-by":"publisher","first-page":"107697","DOI":"10.1016\/j.jmgm.2020.107697","volume":"100","author":"K Terali","year":"2020","unstructured":"Terali K, Baddal B, G\u00fclcan HO (2020) Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: insights from a molecular mechanics-assisted structure-based virtual screening experiment. J Mol Graph Model 100:107697","journal-title":"J Mol Graph Model"},{"key":"4816_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.00102-14","volume":"28","author":"JFW Chan","year":"2015","unstructured":"Chan JFW, Lau SKP, To KKW et al (2015) Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 28:465\u2013522","journal-title":"Clin Microbiol Rev"},{"key":"4816_CR8","doi-asserted-by":"publisher","unstructured":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"4816_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395:565\u2013574","journal-title":"Lancet"},{"key":"4816_CR10","unstructured":"Organization WH, others (2020) Solidarity\u201d clinical trial for COVID-19 treatments. World Heal Organ (WHO) Situat reports Geneva WHO[Accessed 5 Apr 2020] Available from https\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov\/solidarity-clinical-trial-for-covid-19"},{"key":"4816_CR11","doi-asserted-by":"crossref","unstructured":"Gupta, M.K., Vemula, S., Donde, R., Gouda, G., Behera, L., Vadde, R.: In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. J. Biomol. Struct. Dyn.\u00a039(7), 2617-2627 (2020)","DOI":"10.1080\/07391102.2020.1751300"},{"key":"4816_CR12","doi-asserted-by":"crossref","unstructured":"Zhang, Y.-Z., Holmes, E.C.: A genomic perspective on the origin and emergence of SARS-CoV-2. Cell. 181(2), 223-227 (2020)","DOI":"10.1016\/j.cell.2020.03.035"},{"key":"4816_CR13","doi-asserted-by":"crossref","unstructured":"Gil, C., Ginex, T., Maestro, I., Nozal, V., Barrado-Gil, L., Cuesta-Geijo, M.\u00c1., Urquiza, J., Ram\u00edrez, D., Alonso, C., Campillo, N.E. and Martinez, A.: COVID-19: drug targets and potential treatments. J. Med. Chem. 63(21), 12359-12386 (2020)","DOI":"10.1021\/acs.jmedchem.0c00606"},{"key":"4816_CR14","doi-asserted-by":"crossref","unstructured":"Kang, S., Yang, M., Hong, Z., Zhang, L., Huang, Z., Chen, X., He, S., Zhou, Z., Zhou, Z., Chen, Q. and Yan, Y.: Crystal structure of SARS-CoV- 2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. Acta Pharm. Sin. B. 10(7), 1228-1238\u00a0(2020)","DOI":"10.1016\/j.apsb.2020.04.009"},{"key":"4816_CR15","doi-asserted-by":"publisher","first-page":"15092","DOI":"10.1038\/ncomms15092","volume":"8","author":"Y Yuan","year":"2017","unstructured":"Yuan Y, Cao D, Zhang Y et al (2017) Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun 8:15092","journal-title":"Nat Commun"},{"key":"4816_CR16","doi-asserted-by":"crossref","unstructured":"Yi, C., Sun, X., Ye, J., Ding, L., Liu, M., Yang, Z., Lu, X., Zhang, Y., Ma, L., Gu, W. and Qu, A.: Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell. Mol. Immunol. 17(6),\u00a0 621-630 (2020)","DOI":"10.1038\/s41423-020-0458-z"},{"key":"4816_CR17","doi-asserted-by":"crossref","unstructured":"Walls, A.C., Park, Y.J., Tortorici, M.A., Wall, A., McGuire, A.T. and Veesler, D.: Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell.\u00a0181(2), 281-292 (2020)","DOI":"10.1016\/j.cell.2020.02.058"},{"key":"4816_CR18","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1126\/science.1085952","volume":"300","author":"PA Rota","year":"2003","unstructured":"Rota PA, Oberste MS, Monroe SS et al (2003) Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (80- ) 300:1394\u20131399","journal-title":"Science (80- )"},{"key":"4816_CR19","doi-asserted-by":"crossref","unstructured":"Chen, Y., Liu, Q. and Guo, D.: Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 92(4), 418-423 (2020)","DOI":"10.1002\/jmv.25681"},{"key":"4816_CR20","doi-asserted-by":"crossref","unstructured":"Goo, J., Jeong, Y., Park, Y.S., Yang, E., Jung, D.I., Rho, S., Park, U., Sung, H., Park, P.G., Choi, J.A. and Seo, S.H.: Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein. Virus Res. 278, 197863 (2020)","DOI":"10.1016\/j.virusres.2020.197863"},{"key":"4816_CR21","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS et al (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (80- ) 367:1260\u20131263","journal-title":"Science (80- )"},{"key":"4816_CR22","doi-asserted-by":"crossref","unstructured":"Hulswit RJG, De Haan CAM, Bosch B-J (2016) Coronavirus spike protein and tropism changes. Advances in virus research. Elsevier, pp 29\u201357","DOI":"10.1016\/bs.aivir.2016.08.004"},{"key":"4816_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nature16988","volume":"531","author":"AC Walls","year":"2016","unstructured":"Walls AC, Tortorici MA, Bosch B-J et al (2016) Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature 531:114\u2013117","journal-title":"Nature"},{"key":"4816_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270\u2013273","journal-title":"Nature"},{"key":"4816_CR25","doi-asserted-by":"crossref","unstructured":"Liu, C. and Zhu, D.: Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19. Medicine in Drug Discovery, p.100056 (2020)","DOI":"10.1016\/j.medidd.2020.100056"},{"key":"4816_CR26","doi-asserted-by":"crossref","unstructured":"Korber, B., Fischer, W., Gnanakaran, S.G., Yoon, H., Theiler, J., Abfalterer, W., Foley, B., Giorgi, E.E., Bhattacharya, T., Parker, M.D. and Partridge, D.G.: Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. BioRxiv. (2020)","DOI":"10.1101\/2020.04.29.069054"},{"key":"4816_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-020-00763-0","volume":"12","author":"AD Davidson","year":"2020","unstructured":"Davidson AD, Williamson MK, Lewis S et al (2020) Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein. Genome Med 12:1\u201315","journal-title":"Genome Med"},{"key":"4816_CR28","doi-asserted-by":"crossref","unstructured":"Wu, C., Zheng, S., Chen, Y. and Zheng, M.: Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV, in the nasal tissue. MedRxiv. (2020)","DOI":"10.1101\/2020.02.11.20022228"},{"key":"4816_CR29","doi-asserted-by":"crossref","unstructured":"Zhang H, Kang Z, Gong H, et al (2020) The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. BioRxiv","DOI":"10.1101\/2020.01.30.927806"},{"key":"4816_CR30","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E et al (2000) A novel angiotensin-converting enzyme--related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87:e1\u2013e9","journal-title":"Circ Res"},{"key":"4816_CR31","doi-asserted-by":"publisher","first-page":"17132","DOI":"10.1074\/jbc.M006723200","volume":"276","author":"H Zhang","year":"2001","unstructured":"Zhang H, Wada J, Hida K et al (2001) Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J Biol Chem 276:17132\u201317139","journal-title":"J Biol Chem"},{"key":"4816_CR32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1152\/physrev.00036.2005","volume":"86","author":"M Paul","year":"2006","unstructured":"Paul M, Poyan Mehr A, Kreutz R (2006) Physiology of local renin-angiotensin systems. Physiol Rev 86:747\u2013803","journal-title":"Physiol Rev"},{"key":"4816_CR33","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan R, Zhang Y, Li Y et al (2020) Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science (80- ) 367:1444\u20131448","journal-title":"Science (80- )"},{"key":"4816_CR34","doi-asserted-by":"crossref","unstructured":"Wang, Q.H., Song, H. and Qi, J.X.: Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2. RCSB PDB. (2020)","DOI":"10.2210\/pdb6lzg\/pdb"},{"key":"4816_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/v12030254","volume":"12","author":"SF Ahmed","year":"2020","unstructured":"Ahmed SF, Quadeer AA, McKay MR (2020) Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses 12:254","journal-title":"Viruses"},{"key":"4816_CR36","doi-asserted-by":"publisher","first-page":"17996","DOI":"10.1074\/jbc.M311191200","volume":"279","author":"P Towler","year":"2004","unstructured":"Towler P, Staker B, Prasad SG et al (2004) ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem 279:17996\u201318007","journal-title":"J Biol Chem"},{"key":"4816_CR37","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1161\/01.HYP.0000146120.29648.36","volume":"44","author":"MJ Huentelman","year":"2004","unstructured":"Huentelman MJ, Zubcevic J, Hernandez Prada JA et al (2004) Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor. Hypertension 44:903\u2013906","journal-title":"Hypertension"},{"key":"4816_CR38","doi-asserted-by":"crossref","unstructured":"Elmezayen, A.D., Al-Obaidi, A., \u015eahin, A.T. and Yelek\u00e7i, K.: Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J. Biomol. Struct. Dyn. 39(8), 2980-2992 (2020)","DOI":"10.1080\/07391102.2020.1758791"},{"key":"4816_CR39","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1128\/AAC.03036-14","volume":"58","author":"J Dyall","year":"2014","unstructured":"Dyall J, Coleman CM, Hart BJ et al (2014) Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother 58:4885\u20134893","journal-title":"Antimicrob Agents Chemother"},{"key":"4816_CR40","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/S0140-6736(03)13615-X","volume":"361","author":"J Cinatl","year":"2003","unstructured":"Cinatl J, Morgenstern B, Bauer G et al (2003) Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361:2045\u20132046","journal-title":"Lancet"},{"key":"4816_CR41","doi-asserted-by":"crossref","unstructured":"Luo, P., Liu, D. and Li, J.: Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19. Int. J. Antimicrob. Agents. 55(6), 105995 (2020)","DOI":"10.1016\/j.ijantimicag.2020.105995"},{"key":"4816_CR42","doi-asserted-by":"crossref","unstructured":"Chen, H. and Du, Q.: Potential natural compounds for preventing SARS-CoV-2 (2019-nCoV) infection. Preprints Med. Pharmacol. 202001.0358.v2. (2020)","DOI":"10.20944\/preprints202001.0358.v3"},{"key":"4816_CR43","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3389\/fimmu.2020.01239","volume":"11","author":"H Murck","year":"2020","unstructured":"Murck H (2020) Symptomatic protective action of glycyrrhizin (Licorice) in Covid-19 infection? Front Immunol 11:1239","journal-title":"Front Immunol"},{"key":"4816_CR44","doi-asserted-by":"publisher","first-page":"105995","DOI":"10.1016\/j.ijantimicag.2020.105995","volume":"55","author":"P Luo","year":"2020","unstructured":"Luo P, Liu D, Li J (2020) Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19. Int J Antimicrob Agents 55:105995","journal-title":"Int J Antimicrob Agents"},{"key":"4816_CR45","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/jmv.25707","volume":"92","author":"L Zhang","year":"2020","unstructured":"Zhang L, Liu Y (2020) Potential interventions for novel coronavirus in China: a systematic review. J Med Virol 92:479\u2013490","journal-title":"J Med Virol"},{"key":"4816_CR46","doi-asserted-by":"crossref","unstructured":"Gomaa, A.A., Abdel-Wadood, Y.A.: The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions. Phytomedicine Plus. 100043 (2021)","DOI":"10.1016\/j.phyplu.2021.100043"},{"key":"4816_CR47","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC et al (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612","journal-title":"J Comput Chem"},{"key":"4816_CR48","doi-asserted-by":"crossref","unstructured":"Chrzanowski, J., Chrzanowska, A., Grabo\u0144, W.: Glycyrrhizin: An old weapon against a novel coronavirus. Phytother. Res. 35(2), 629-636 (2021)","DOI":"10.1002\/ptr.6852"},{"key":"4816_CR49","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC et al (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46:D1074\u2013D1082","journal-title":"Nucleic Acids Res"},{"key":"4816_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA et al (2011) Open Babel: an open chemical toolbox. J Cheminform 3:33","journal-title":"J Cheminform"},{"key":"4816_CR51","doi-asserted-by":"crossref","unstructured":"Irwin, J.J.: Software Review: ChemOffice 2005 Pro by CambridgeSoft. (2005)","DOI":"10.1021\/ci050286x"},{"key":"4816_CR52","doi-asserted-by":"crossref","unstructured":"Halgren TA (1996) Merck molecular force field. J Comput Chem 17:490\u2013519.","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P"},{"key":"4816_CR53","doi-asserted-by":"crossref","unstructured":"Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx. Chemical biology. Springer, pp 243\u2013250","DOI":"10.1007\/978-1-4939-2269-7_19"},{"key":"4816_CR54","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461","journal-title":"J Comput Chem"},{"key":"4816_CR55","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.3390\/app9214538","volume":"9","author":"TF Vieira","year":"2019","unstructured":"Vieira TF, Sousa SF (2019) Comparing AutoDock and Vina in ligand\/decoy discrimination for virtual screening. Appl Sci 9:4538","journal-title":"Appl Sci"},{"key":"4816_CR56","unstructured":"Lee, S.K., Lee, I.H., Kim, H.J., Chang, G.S., Chung, J.E. and No, K.T.: The PreADME Approach: Web-based program for rapid prediction of physico-chemical, drug absorption and drug-like properties. EuroQSAR designing drugs and crop protectants: processes, problems and solutions, pp.418-20 (2003)"},{"key":"4816_CR57","unstructured":"Case, D.A., Walker, R.C. Cheatham, T.E.: Amber 18, Univ. California, San Fr. (2018)"},{"key":"4816_CR58","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW et al (2004) Development and testing of a general amber force field. J Comput Chem 25:1157\u20131174","journal-title":"J Comput Chem"},{"key":"4816_CR59","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA, Martinez C, Kasavajhala K et al (2015) ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 11:3696\u20133713","journal-title":"J Chem Theory Comput"},{"key":"4816_CR60","first-page":"U403","volume":"222","author":"J Wang","year":"2001","unstructured":"Wang J, Wang W, Kollman PA, Case DA (2001) Antechamber: an accessory software package for molecular mechanical calculations. J Am Chem Soc 222:U403","journal-title":"J Am Chem Soc"},{"key":"4816_CR61","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P","volume":"21","author":"A Jakalian","year":"2000","unstructured":"Jakalian A, Bush BL, Jack DB, Bayly CI (2000) Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method. J Comput Chem 21:132\u2013146","journal-title":"J Comput Chem"},{"key":"4816_CR62","unstructured":"Schafmeister C, Ross WS, Romanovski V (1995) The leap module of AMBER. Univ Calif"},{"key":"4816_CR63","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1063\/1.470043","volume":"103","author":"HG Petersen","year":"1995","unstructured":"Petersen HG (1995) Accuracy and efficiency of the particle mesh Ewald method. J Chem Phys 103:3668\u20133679","journal-title":"J Chem Phys"},{"key":"4816_CR64","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","volume":"22","author":"V Kr\u00e4utler","year":"2001","unstructured":"Kr\u00e4utler V, Van Gunsteren WF, H\u00fcnenberger PH (2001) A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J Comput Chem 22:501\u2013508","journal-title":"J Comput Chem"},{"key":"4816_CR65","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/S0092-8674(03)00976-0","volume":"115","author":"DS Dimitrov","year":"2003","unstructured":"Dimitrov DS (2003) The secret life of ACE2 as a receptor for the SARS virus. Cell 115:652\u2013653","journal-title":"Cell"},{"key":"4816_CR66","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe DR, Cheatham III TE (2013) PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput 9:3084\u20133095","journal-title":"J Chem Theory Comput"},{"key":"4816_CR67","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33\u201338","journal-title":"J Mol Graph"},{"key":"4816_CR68","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller","year":"2012","unstructured":"Miller BR, McGee TD, Swails JM et al (2012) MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput 8:3314\u20133321. https:\/\/doi.org\/10.1021\/ct300418h","journal-title":"J Chem Theory Comput"},{"key":"4816_CR69","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discovery 10:449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discovery"},{"key":"4816_CR70","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0166-3542(02)00185-7","volume":"58","author":"JM Crance","year":"2003","unstructured":"Crance JM, Scaramozzino N, Jouan A, Garin D (2003) Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antivir Res 58:73\u201379","journal-title":"Antivir Res"},{"key":"4816_CR71","doi-asserted-by":"crossref","unstructured":"Bailly, C. Vergoten, G.: Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?. Pharmacol. Ther. p.107618 (2020)","DOI":"10.1016\/j.pharmthera.2020.107618"},{"key":"4816_CR72","doi-asserted-by":"crossref","unstructured":"Morris GM, Lim-Wilby M (2008) Molecular docking. Molecular modeling of proteins. Springer, pp 365\u2013382","DOI":"10.1007\/978-1-59745-177-2_19"},{"key":"4816_CR73","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"X-Y Meng","year":"2011","unstructured":"Meng X-Y, Zhang H-X, Mezei M, Cui M (2011) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 7:146\u2013157","journal-title":"Curr Comput Aided Drug Des"},{"key":"4816_CR74","unstructured":"Menchaca TM, Ju\u00e1rez-Portilla C, Zepeda RC (2020) Past, present, and future of molecular docking. Drug Discovery and Development-New Advances. IntechOpen"},{"key":"4816_CR75","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/molecules200713384","volume":"20","author":"LG Ferreira","year":"2015","unstructured":"Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD (2015) Molecular docking and structure-based drug design strategies. Molecules 20:13384\u201313421","journal-title":"Molecules"},{"key":"4816_CR76","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1741-7007-9-71","volume":"9","author":"JD Durrant","year":"2011","unstructured":"Durrant JD, McCammon JA (2011) Molecular dynamics simulations and drug discovery. BMC Biol 9:71","journal-title":"BMC Biol"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-021-04816-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-021-04816-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-021-04816-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T08:54:27Z","timestamp":1699174467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-021-04816-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4816"],"URL":"https:\/\/doi.org\/10.1007\/s00894-021-04816-y","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]},"assertion":[{"value":"6 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"206"}}